JUUL Labs Agrees to Pay $130,000 Settlement in Florida Lawsuit

Business by 2FIRSTS.ai
Dec.20.2023
JUUL Labs Agrees to Pay $130,000 Settlement in Florida Lawsuit
JUUL Labs, a prominent US e-cigarette company, has agreed to pay $130,000 to resolve lawsuits alleging deceptive marketing to minors.

On December 18th, the prominent e-cigarette company JUUL Labs reached a unanimous decision to settle a lawsuit by paying a settlement amount of $130,000 to Osceola County, Florida. This resolution effectively resolves the lawsuit filed by Osceola County in December 2022, as well as collective legal actions initiated by various governments and school districts across the United States. The lawsuits primarily revolve around allegations stating that JUUL engaged in deceptive marketing practices targeting minors and downplaying the addictive nature of smoking.

 

Since April, JUUL has reached settlements with 47 states and territories, over 5,000 individuals, and local governments nationwide. Oswego County intends to allocate the $138,000 settlement amount towards addressing youth smoking and nicotine addiction.

 

Mark Pino, spokesperson for Osceola County, stated that while it is still too early to determine the specific use, Blake Warren, the executive director of the Central Florida Health Education Center, expressed support for it. Last year, the center's smoking cessation program saw an increase in adult participants, with 3000 individuals taking part, compared to previous years.

 

Warren believes that smoking e-cigarettes is as harmful as smoking traditional cigarettes, and he hopes that settlement funds will be used for prevention programs targeting young people. He emphasizes that implementing more prevention programs in elementary and middle schools can persuade children at an early age not to start smoking, which is crucial in preventing them from struggling to quit smoking later on.

 

JUUL has reached settlements with 47 states and territories, as well as 5,000 individual and local governments nationwide, with more settlements still pending.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Cytisinicline has been submitted for FDA approval and, if approved, would become the first non-nicotine smoking cessation drug in 20 years.
Jul.07 by 2FIRSTS.ai
US Study: Inadequate Nicotine Pouch Packaging Sparks Concerns Over Child Safety
US Study: Inadequate Nicotine Pouch Packaging Sparks Concerns Over Child Safety
A new study shows a 760% surge in nicotine poisoning cases among children under six, with novel nicotine pouches identified as the main culprit. Experts are calling for stronger child safety protections.
Jul.16 by 2FIRSTS.ai
U.S. Senate Panel Approves $200 Million for FDA to Crack Down on Illegal E-Cigarettes and Nicotine Pouches, and Urges Faster Product Reviews
U.S. Senate Panel Approves $200 Million for FDA to Crack Down on Illegal E-Cigarettes and Nicotine Pouches, and Urges Faster Product Reviews
The U.S. Senate Appropriations Committee approved $200 million for the FDA to crack down on illegal e-cigarettes and nicotine pouches and urged faster premarket product reviews. The bill now moves to the full Senate and still requires further approval and presidential signing.
Jul.15
Denssi's Global Strategy: Swedish Nicotine Pouch Brand Focuses on Flavor Innovation, Brand Storytelling in Africa and Middle East
Denssi's Global Strategy: Swedish Nicotine Pouch Brand Focuses on Flavor Innovation, Brand Storytelling in Africa and Middle East
Denssi COO Callum Cherry highlights that the brand stands out globally with “great flavors” and a unique story. Using differentiated strategies and sports sponsorships, Denssi builds a youthful, passionate image, focusing on emerging markets in Africa and the Middle East.
Jun.19 by 2FIRSTS.ai
Philippines NBI Cracks Down on Illegal Vapes in July, Announces Third Enforcement Case
Philippines NBI Cracks Down on Illegal Vapes in July, Announces Third Enforcement Case
The Philippines’ National Bureau of Investigation (NBI) has intensified its crackdown on the illegal vape market, launching a series of large-scale sting operations. Since July, the NBI has dismantled illegal e-cigarette distribution networks in several regions, arrested multiple suspects, and seized unregistered vape products worth millions of pesos.
Jul.08
Product|BAT Japan Launches glo Hilo with 5-Second Heat-up Time in Japan
Product|BAT Japan Launches glo Hilo with 5-Second Heat-up Time in Japan
BAT Japan has launched its latest heated tobacco device, glo Hilo, in Miyagi Prefecture on June 9. The device features a 5-second preheat time and Bluetooth connectivity with the “myglo” app, allowing users to track puff count and customize session duration. It is priced at ¥3,980 (approximately $23.44).
Jun.09 by 2FIRSTS.ai